Clinical Trials Logo

Non-communicable Disease clinical trials

View clinical trials related to Non-communicable Disease.

Filter by:
  • Enrolling by invitation  
  • Page 1

NCT ID: NCT03473795 Enrolling by invitation - Clinical trials for Non-Communicable Disease

Developing Non-Communicable Disease Registries in Africa : A Step Towards Providing Quality Data for Improving Patient Outcomes

Start date: March 16, 2018
Phase:
Study type: Observational [Patient Registry]

This umbrella protocol seeks to develop robust data registries for non-communicable diseases (NCDs) in sub-Saharan Africa (SSA) with the aim of providing accurate and comprehensive data for the evaluation of such diseases in sub-Saharan African countries.Healthy volunteers will be included in the study for comparison. Additionally, the investigators aim to describe the gut microbiome community diversity of a cohort of community dwelling Nigerians and compare with CRC patients in Nigerian and at MSK. We will collect stool for microbiome and metabolomic analysis from community dwelling persons in the catchment area of ARGO facilities in Nigeria while contemporaneously administering an extensive medical and environmental exposure questionnaire.

NCT ID: NCT03312439 Enrolling by invitation - Clinical trials for Cardiovascular Diseases

Effects of Primary Prevention in Elderly People-The Healthy Aging Initiative

HAI
Start date: June 1, 2012
Phase: N/A
Study type: Interventional

The number of elderly will increase rapidly in Europe in the next 30 years, which affects the country's economic and social development, welfare, health care, and also the individuals. Future challenges include creating opportunities for people to maintain a high well-being in later stages of life, and coping with diseases and disability. Physical exercise and avoiding obesity have the potential to increase quality of life in the elderly by preventing CVD and stroke. The proposed project is a intervention study where the overarching aim is to evaluate whether a primary prevention with the focus of decreasing obesity and increasing objective measures of physical activity will decrease the future risk of the endpoints cardiovascular disease, stroke, diabetes, falls, fractures, dementia and death, in a population based cohort of 70-year-old women and men. Specific aims: In a population based cohort of 5000, 70-year old women and men; 1. Investigate the association between risk factors assessed at baseline, with focus on objective measures of physical activity and body fat distribution, and the endpoints described above. 2. To investigate whether individuals given the prevention will have a lower future risk of the endpoints described above than 70-year olds in general Swedish population, after adjustments for differences in the different covariates at baseline. In a second part, a follow up will be conducted after 5 years where all participants will be tested again. One aim is to evaluate whether the changes in the risk factors assessed at baseline, with focus of objective measures of physical activity and body fat distribution, are associated with the risk of CVD and stroke. We will also again investigate whether the intervention give will influence the future risk of non-communicable disease.